Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other financing activities (2016 - 2025)

Historic Other financing activities for Niagen Bioscience (NAGE) over the last 14 years, with Q2 2025 value amounting to $6000.0.

  • Niagen Bioscience's Other financing activities changed N/A to $6000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $53000.0, marking a year-over-year decrease of 3837.21%. This contributed to the annual value of $52000.0 for FY2024, which is 3066.67% down from last year.
  • According to the latest figures from Q2 2025, Niagen Bioscience's Other financing activities is $6000.0.
  • Niagen Bioscience's 5-year Other financing activities high stood at $75000.0 for Q4 2023, and its period low was $3000.0 during Q2 2021.
  • For the 5-year period, Niagen Bioscience's Other financing activities averaged around $32600.0, with its median value being $28000.0 (2022).
  • Examining YoY changes over the last 5 years, Niagen Bioscience's Other financing activities showed a top increase of 23157.89% in 2021 and a maximum decrease of 8000.0% in 2021.
  • Over the past 5 years, Niagen Bioscience's Other financing activities (Quarter) stood at $63000.0 in 2021, then fell by 1.59% to $62000.0 in 2022, then grew by 20.97% to $75000.0 in 2023, then crashed by 45.33% to $41000.0 in 2024, then plummeted by 85.37% to $6000.0 in 2025.
  • Its Other financing activities stands at $6000.0 for Q2 2025, versus $6000.0 for Q1 2025 and $41000.0 for Q4 2024.